nervous system
N |
• no signs of immune cell infiltrates are detected
|
• develop convulsions by 1.5 months of age
|
• thickened astrocytic processes are seen in the optic nerve
|
• optic nerves display areas of myelinolysis and thinly myelinated axons
• gene dosage correlated decrease in myelinated fiber density and myelin thickness
• however, no defects in myelin are detected in the peripheral nervous system (assayed in the sciatic nerve)
|
• show clinical signs of demyelination (tail droop, shaky gait, head shaking, convulsions, impaired righting response, reduced physical activity) by 1.5 months of age
• signs increase in severity with age more rapidly than in hemizygous mice
• decrease in myelination and irregular axonal staining in the brain
• myelin degradation, nude axons and thinly myelinated axons in the presence of myelinolysis are seen in the optic nerve
|
behavior/neurological
• display proprioceptive positioning defects at 4 months of age
• effects are more severe than in hemizygous mice
|
• becomes impaired by 1.5 months of age
|
• at 4 months of age
• effects are more severe than in hemizygous mice
|
• at 4 months of age
• effects are more severe than in hemizygous mice
|
• develop tail droop by 1.5 months of age
|
head shaking
(
J:142650
)
• develops by 1.5 months of age
|
• develop a shaky gait by 1.5 months of age
• at 4 months of age the gait abnormality is more severe in the hind limbs
|
• develop convulsions by 1.5 months of age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
multiple sclerosis | DOID:2377 |
OMIM:612594 OMIM:612595 OMIM:612596 |
J:142650 |